These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11585493)

  • 21. US skimps on genetic screening.
    New Sci; 1978 Feb; 77(1090):412. PubMed ID: 11663825
    [No Abstract]   [Full Text] [Related]  

  • 22. MSJAMA. Between a rock and a hard place.
    Garrison A
    JAMA; 2003 Sep; 290(9):1217-8. PubMed ID: 12953008
    [No Abstract]   [Full Text] [Related]  

  • 23. msJAMA. Genomic medicine: managing the complexity.
    Phillips JA
    JAMA; 2001 Oct; 286(13):1639. PubMed ID: 11585494
    [No Abstract]   [Full Text] [Related]  

  • 24. The likely financial effects on individuals, industry and commerce of the use of genetic information.
    Ross T
    Philos Trans R Soc Lond B Biol Sci; 1997 Aug; 352(1357):1103-6. PubMed ID: 9304677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MSJAMA. Genetic information and competing interests.
    Ihler E
    JAMA; 2003 Sep; 290(9):1216. PubMed ID: 12953007
    [No Abstract]   [Full Text] [Related]  

  • 26. Cost-benefit analysis in genetic disorders.
    Lubs ML
    Am J Med Genet; 1980; 6(4):331-2. PubMed ID: 6782880
    [No Abstract]   [Full Text] [Related]  

  • 27. [To what extent can the publicly sponsored health system afford predictive genetic diagnostics?--first approaches to pinpoint and limit responsibilities, exemplified by hereditary carcinomas].
    Wild C; Jonas S
    Gesundheitswesen; 2003 Jun; 65(6):351-8. PubMed ID: 12836125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of genetic testing on primary care: where's the beef?
    Wulfsberg EA
    Am Fam Physician; 2000 Feb; 61(4):971-2, 974, 977-8. PubMed ID: 10706153
    [No Abstract]   [Full Text] [Related]  

  • 29. [Implementation of Italian guidelines on public health genomics in Italy: a challenging policy of the NHS].
    Boccia S; Federici A; Colotto M; Villari P
    Epidemiol Prev; 2014; 38(6 Suppl 2):29-34. PubMed ID: 25759340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Whole Genome and Whole Exome Sequencing in Preventive Genomic Sequencing Programs.
    Bertier G; Zawati MH; Joly Y
    Am J Bioeth; 2015; 15(7):22-4. PubMed ID: 26147258
    [No Abstract]   [Full Text] [Related]  

  • 31. Looking for Trouble: Preventive Genomic Sequencing in the General Population and the Role of Patient Choice.
    Lázaro-Muñoz G; Conley JM; Davis AM; Van Riper M; Walker RL; Juengst ET
    Am J Bioeth; 2015; 15(7):3-14. PubMed ID: 26147254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preventive Genomic Sequencing and Care of the Individual Patient.
    Char D
    Am J Bioeth; 2015; 15(7):32-3. PubMed ID: 26147263
    [No Abstract]   [Full Text] [Related]  

  • 33. Genetic risk assessment and insurance.
    Reilly PR
    Genet Test; 1998; 2(1):1-2. PubMed ID: 10464590
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical indications for genetic testing in familial sudden cardiac death syndromes: an HRUK position statement.
    Heart Rhythm UK Familial Sudden Death Syndromes Statement Development Group
    Heart; 2008 Apr; 94(4):502-7. PubMed ID: 17664186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double Trouble: Preventive Genomic Sequencing and the Case of Minors.
    Hens K; Dierickx K
    Am J Bioeth; 2015; 15(7):30-1. PubMed ID: 26147262
    [No Abstract]   [Full Text] [Related]  

  • 36. Preventive Genomic Sequencing in the General Population: Do PGS Fly?
    Cho MK
    Am J Bioeth; 2015; 15(7):1-2. PubMed ID: 26147253
    [No Abstract]   [Full Text] [Related]  

  • 37. [Significance of an adequate design in genetic diagnosis protocols].
    Perez-Soriano C; Adam V; Martinez-Costa C; Garcia-Garcia AB
    Med Clin (Barc); 2014 Apr; 142(8):375-6. PubMed ID: 24012447
    [No Abstract]   [Full Text] [Related]  

  • 38. Ethics Preparedness for Public Health Emergencies: Recommendations From the Presidential Bioethics Commission.
    Fenton E; Chillag K; Michael NL
    Am J Bioeth; 2015; 15(7):77-9. PubMed ID: 26147281
    [No Abstract]   [Full Text] [Related]  

  • 39. Patient Choice and Preventive Genomic Sequencing--More Trouble Upstream.
    Holm S; Ploug T
    Am J Bioeth; 2015; 15(7):24-6. PubMed ID: 26147259
    [No Abstract]   [Full Text] [Related]  

  • 40. Response to Open Peer Commentaries on "Looking for Trouble: Preventive Genomic Sequencing in the General Population and the Role of Patient Choice".
    Lázaro-Muñoz G; Conley JM; Davis AM; Van Riper M; Walker RL; Juengst ET
    Am J Bioeth; 2015; 15(12):W6-9. PubMed ID: 26632375
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.